Labeler
Rising Pharma Holdings, Inc. NDC Codes
Rising Pharma Holdings, Inc. lists 529 finished drug products in the FDA NDC Directory under NDC labeler codes 16571, 57237, 64980.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Buspirone Hydrochloride, Memantine Hydrochloride, Albuterol Sulfate, Enalapril Maleate, Trazodone Hydrochloride, Spironolactone, Lorazepam, sumatriptan, Mexiletine Hydrochloride, Carbidopa and Levodopa, Timolol Maleate, Oxybutynin Chloride, azithromycin, Dimetane, Ranitidine
- Active ingredients
- Buspirone hydrochloride, Albuterol sulfate, Memantine hydrochloride, Enalapril maleate, Trazodone hydrochloride, Spironolactone, Lorazepam, Acetaminophen, Sumatriptan succinate, Cyclobenzaprine hydrochloride, Mexiletine hydrochloride, Carbidopa
- NDC labeler codes
- 16571, 57237, 64980
- Strengths (from the 100 most recently listed products)
- Guaifenesin 100 mg/5mL; Cetirizine hydrochloride 1 mg/mL; Levodopa 100 mg/1; Carbidopa 25 mg/1; Phenoxybenzamine hydrochloride 10 mg/1; Famotidine 40 mg/5mL; Oxybutynin chloride 2.5 mg/1; Azithromycin dihydrate 500 mg/1; Azithromycin dihydrate 250 mg/1; Esomeprazole magnesium 20 mg/1; Oxybutynin chloride 5 mg/1; Entacapone 200 mg/1; Sodium phosphate, Dibasic, Anhydrous 852 mg/1; Potassium phosphate, Monobasic 155 mg/1; Sodium phosphate, Monobasic, Monohydrate 130 mg/1; Clindamycin phosphate 10 mg/mL; Buspirone hydrochloride 5 mg/1; Buspirone hydrochloride 7.5 mg/1; Buspirone hydrochloride 10 mg/1; Buspirone hydrochloride 15 mg/1
- Dosage forms
- Tablet, Solution, Tablet, Film coated, Capsule, Cream, Capsule, Extended release, Tablet, Extended release, Suppository, Tablet, Delayed release, Tablet, Orally disintegrating, Capsule, Liquid filled, Liquid, Inhalant, Powder, For suspension, Capsule, Delayed release, Injection, Solution
- Routes
- Oral, Respiratory (Inhalation), Topical, Rectal, Ophthalmic, Intramuscular
- Drug classes (FDA established)
- Histamine-1 Receptor Antagonist, beta-Adrenergic Blocker, beta2-Adrenergic Agonist, Antiarrhythmic, N-methyl-D-aspartate Receptor Antagonist, Angiotensin Converting Enzyme Inhibitor, Serotonin Reuptake Inhibitor, Histamine-2 Receptor Antagonist, Proton Pump Inhibitor, Aldosterone Antagonist, Benzodiazepine, Anticholinergic, Serotonin-1b and Serotonin-1d Receptor Agonist, Central alpha-2 Adrenergic Agonist, Muscle Relaxant, Aromatic Amino Acid, Cholinergic Muscarinic Antagonist, Macrolide Antimicrobial, Expectorant, Azole Antifungal, Aminosalicylate, Non-Standardized Chemical Allergen, Monoamine Oxidase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Corticosteroid, Osmotic Laxative, Potassium Salt, Anti-coagulant, Calculi Dissolution Agent, alpha-Adrenergic Blocker, Catechol-O-Methyltransferase Inhibitor, Lincosamide Antibacterial, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Amide Local Anesthetic, Cephalosporin Antibacterial, Carbonic Anhydrase Inhibitor, Copper Absorption Inhibitor, Kinase Inhibitor, mTOR Inhibitor Immunosuppressant, Central Nervous System Stimulant, Methylxanthine
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 180 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride 10 mg/1 | CapsuleOral | 16571-874 | 16571-0874-01 | — |
| Famotidine | Famotidine 40 mg/5mL | Powder, For suspensionOral | 64980-737 | 64980-0737-50 | — |
| Oxybutynin Chloride | Oxybutynin chloride 2.5 mg/1 | TabletOral | 64980-734 | 64980-0734-01 | — |
| azithromycin | Azithromycin dihydrate 500 mg/1 | Tablet, Film coatedOral | 64980-726 | 64980-0726-0364980-0726-13 | — |
| azithromycin | Azithromycin dihydrate 250 mg/1 | Tablet, Film coatedOral | 64980-727 | 64980-0727-0364980-0727-16 | — |
| Esomeprazole Magnesium | Esomeprazole magnesium 20 mg/1 | Capsule, Delayed releaseOral | 64980-664 | 64980-0664-1964980-0664-41 | — |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | 64980-679 | 64980-0679-0164980-0679-1064980-0679-50 | — |
| Entacapone | Entacapone 200 mg/1 | Tablet, Film coatedOral | 64980-722 | 64980-0722-01 | — |
| Phospha 250 Neutraldibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate | Sodium phosphate, Dibasic, Anhydrous 852 mg/1 + 2 more ingredients | TabletOral | 64980-729 | 64980-0729-01 | — |
| Clindamycin Phosphate | Clindamycin phosphate 10 mg/mL | SolutionTopical | 16571-256 | 16571-0256-6016571-0256-69 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 5 mg/1 | TabletOral | 64980-650 | 64980-0650-0164980-0650-0664980-0650-50 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 7.5 mg/1 | TabletOral | 64980-651 | 64980-0651-0164980-0651-50 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 10 mg/1 | TabletOral | 64980-652 | 64980-0652-0164980-0652-0664980-0652-50 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 15 mg/1 | TabletOral | 64980-653 | 64980-0653-0164980-0653-0664980-0653-50 | — |
| Buspirone Hydrochloride | Buspirone hydrochloride 30 mg/1 | TabletOral | 64980-654 | 64980-0654-0664980-0654-50 | — |
| AQUASOL A Parenteralwater-miscible retinyl palmitate | Vitamin a palmitate 15 mg/mL | Injection, SolutionIntramuscular | 64980-721 | 64980-0721-02 | — |
| Dimetanediphenhydramine hydrochloride | Diphenhydramine hydrochloride 25 mg/1 | Capsule, Liquid filledOral | 57237-367 | 57237-0367-0157237-0367-99 | — |
| Dimetanediphenhydramine hydrochloride | Diphenhydramine 50 mg/1 | Capsule, Liquid filledOral | 57237-368 | 57237-0368-0157237-0368-99 | — |
| Mucolyteguaifenesin | Guaifenesin 100 mg/5mL | LiquidOral | 57237-359 | 57237-0359-1257237-0359-16 | — |
| Mucolyte DMguaifenesin, dextromethorphan hbr | Guaifenesin 100 mg/5mL; Dextromethorphan hydrobromide 10 mg/5mL | LiquidOral | 57237-360 | 57237-0360-1257237-0360-16 | — |
| Lidonumblidocaine 5% | Lidocaine .05 g/g | CreamTopical | 57237-353 | 57237-0353-1557237-0353-30 | — |
| Pedikleertolnaftate | Tolnaftate 1 g/100g | CreamTopical | 57237-354 | 57237-0354-1557237-0354-30 | — |
| Jointivatrolamine salicylate 10% | Trolamine salicylate 10 g/100g | CreamTopical | 57237-355 | 57237-0355-85 | — |
| Cefixime | Cefixime 400 mg/1 | TabletOral | 64980-430 | 64980-0430-01 | — |
| Ranitidine | Ranitidine hydrochloride 150 mg/1 | TabletOral | 64980-636 | 64980-0636-03 | — |
| Ranitidine | Ranitidine hydrochloride 300 mg/1 | TabletOral | 64980-637 | 64980-0637-03 | — |
| Dichlorphenamide | Dichlorphenamide 50 mg/1 | TabletOral | 16571-242 | 16571-0242-01 | — |
| Cetirizine Hydrochloride | Cetirizine hydrochloride 1 mg/mL | SolutionOral | 57237-357 | 57237-0357-1257237-0357-24 | — |
| Cetirizine Hydrochloride | Cetirizine hydrochloride 1 mg/mL | SolutionOral | 57237-358 | 57237-0358-1257237-0358-24 | — |
| Micoclearclotrimazole antifungal | Clotrimazole 10 mg/g | CreamTopical | 57237-350 | 57237-0350-1557237-0350-3057237-0350-45 | — |
| Coolexacamphor, menthol, methyl salicylate | Camphor (Synthetic) 40 mg/g + 2 more ingredients | CreamTopical | 57237-351 | 57237-0351-1357237-0351-57 | — |
| ItchZapdiphenhydramine hydrochloride and zinc acetate | Diphenhydramine hydrochloride 20 mg/g; Zinc acetate 1 mg/g | CreamTopical | 57237-352 | 57237-0352-28 | — |
| Sodium Chloride | Sodium chloride 1000 mg/1 | TabletOral | 57237-361 | 57237-0361-01 | — |
| Sulfasalazine | Sulfasalazine 500 mg/1 | TabletOral | 16571-261 | 16571-0261-0116571-0261-30 | — |
| Spironolactone | Spironolactone 25 mg/1 | TabletOral | 64980-706 | 64980-0706-0164980-0706-50 | — |
| Spironolactone | Spironolactone 50 mg/1 | TabletOral | 64980-707 | 64980-0707-0164980-0707-50 | — |
| Spironolactone | Spironolactone 100 mg/1 | TabletOral | 64980-708 | 64980-0708-0164980-0708-50 | — |
| Proctozone-Gglycerin | Glycerin 1.2 g/1 | SuppositoryRectal | 57237-338 | 57237-0338-2157237-0338-52 | — |
| Proctozone GMaxglycerin | Glycerin 2 g/1 | SuppositoryRectal | 57237-339 | 57237-0339-2157237-0339-52 | — |
| Lorazepam | Lorazepam .5 mg/1 | TabletOral | 64980-627 | 64980-0627-0164980-0627-1064980-0627-50 | — |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | 64980-628 | 64980-0628-0164980-0628-1064980-0628-50 | — |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | 64980-629 | 64980-0629-0164980-0629-1064980-0629-50 | — |
| Rasagilinerasagiline mesylate | Rasagiline mesylate .5 mg/1 | TabletOral | 64980-711 | 64980-0711-30 | — |
| Rasagilinerasagiline mesylate | Rasagiline mesylate 1 mg/1 | TabletOral | 64980-712 | 64980-0712-30 | — |
| Sirolimus | Sirolimus 1 mg/mL | SolutionOral | 16571-806 | 16571-0806-06 | — |
| Bisoprolol Fumarate | Bisoprolol fumarate 5 mg/1 | Tablet, Film coatedOral | 64980-709 | 64980-0709-0164980-0709-03 | — |
| Bisoprolol Fumarate | Bisoprolol fumarate 10 mg/1 | Tablet, Film coatedOral | 64980-710 | 64980-0710-0164980-0710-03 | — |
| Acetaminophen | Acetaminophen 325 mg/1 | Tablet, Film coatedOral | 57237-346 | 57237-0346-0157237-0346-10 | — |
| Acetaminophen | Acetaminophen 500 mg/1 | Tablet, Film coatedOral | 57237-347 | 57237-0347-0157237-0347-05 | — |
| Acetaminophen, Aspirin and Caffeine | Acetaminophen 250 mg/1 + 2 more ingredients | TabletOral | 57237-348 | 57237-0348-01 | — |
Rising Pharma Holdings, Inc.: common questions
- What is Rising Pharma Holdings, Inc.'s NDC labeler code?
- 16571, 57237, 64980. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Rising Pharma Holdings, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.